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The microbiota is the community of microorganisms living on and in a biological 
system. It has shown to play a role in a broad range of medical conditions, 
including cardiovascular diseases. Germ-free (GF) mice grew under the condition lacking 
all microorganisms, in contrast to conventionally raised (CONV-R) mice  
colonized with a diverse microbiota. GF mice play a key role as tools to reveal the 
the causal relationship between microbiome and disease. In particular, GF mice present 
significant cardiac functional defects compared to CONV-R mice. The project's goal was 
to determine the spatial impact of GF vs. CONV-R status on cardiac metabolism across 
cardiac regions. 4 metabolite molecules showed significant differences by Random Forest 
analysis based on untargeted liquid chromatography-tandem mass spectrometry data. The 
four molecules are neighborhood of ADP-ribose (m/z = 588.11), ergothioneine (m/z = 
230.1), neighborhood of dodecanoic acid (m/z = 177.13), and L-glutamine (m/z = 
130.05). (Neighborhood results were generated from molecular networking.) Parallel 
reaction monitoring (PRM) was applied to provide more precise quantification results. In 
most locations, peak abundance significant difference was mapping in the locations: right 
ventricle free wall and left atrium part between germ-free and CONV-R conditions. 
Ergothioneine showed a difference in the left ventricle free wall bottom section. The 
metabolites may relate to the presence of microbiome and contribute to reducing the risk 






The microbiome is the community of all microbes living inside or on an 
environment, including bacteria, fungi, protozoa, and viruses[1]. The human 
microbiome is the community of the human body. The sponge microbiome is the 
community living on a sponge, and so on. It has an influence on various aspects 
such as metabolism, nutrition, and immunity of the host[2,3], so it has aroused great 
interest in biomedical research. The microbiome evolves from birth to death in a 
host. The continuous evolution of the human microbiome after birth is influenced 
by host factors (such as innate and adaptive immune systems), external factors 
(such as diet, drug and toxin exposure), and diseases[4]. The gut microbiome 
attracts particular interest because of its evolution across the entire lifespan, its 
connection to health, and its potential role in the development of cardiovascular 
disease (CVD)[5].  
 
With the increasing importance of the gut microbiome as a necessary condition to 
maintain the balance of health vs. disease, interest in the manipulation of the gut 
microbiome in the mouse model has increased accordingly. Germ-free mice are 
bred in isolators, which prevent entirely microbial contact so that they are not 
affected by any detectable microbe community. Louis Pasteur and his colleague 
first brought out this concept in 1885, and germ-free mice colonies were initially 
generated in the 1940s. Germ-free mice models enable the study of animals that 
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are completely free of microorganisms or colonized with known 
microorganisms[6–8].  
 
Prior work by collaborators at the University of Wisconsin-Madison (Dr. Federico 
Rey group) showed that microbiota colonization of previously germ-free mice for 
two weeks had minor influences on the left ventricle's thickness (LV) walls while 
significantly reducing the LV end volume. The mass of the LV of colonized mice 
was significantly increased compared to germ-free animals. Colonization also 
significantly increased the LV ejection fraction and had minor influences on 
stroke volume and cardiac output. 
 
Cardiovascular disease (CVD) is caused by genetic, environmental, or a 
combination of genetic and environmental sources. Although extensive 
investigations have been carried out to find causal genetic variations, such as 
large-scale GWAS, genetic determinants cause less than one-fifth of 
cardiovascular risk. Now the diverse microbes residing in human gut have 
overwhelmed the number of 100 trillion, which is far more than the human host 
cells.  In the past several decades, researchers have observed that intestinal 
microbiota, as an active participant, plays an active role in the growth of 






The mammalian microbiota represents a critical function in the pathogenesis of 
many illnesses. Due to the latest genomics, proteomics, and metabolomics, it is 
now possible to study the microbial components and metabolic activities in detail. 
The microbiota plays an essential role in the formation of healthy individuals, 
which changes the composition or function of intestinal microbiota 
(maladjustment), has specific harmful microorganisms (pathogenic bacteria), or 
lack of protective microorganisms may lead to immune and metabolism mediated 
diseases and cancers[10]. Due to the mechanism involved, these diseases may not 
be limited to digestive tract diseases[11]. 
 
 
Metabolomics is the scientific study of small molecules, commonly known as 
metabolites, such as ketone body β-hydroxybutyrate (BHB)[12], which is 
synthesized through fatty acids in the liver. When the glucose supply is too low to 
meet the body's energy needs, such as long-term exercise, starvation, or lack of 
dietary carbohydrates, BHB is an important energy carrier to the peripheral tissues 
from the liver. In 1987, Horrobin and his research group found metabolites of 
linoleic acid could decrease plasma cholesterol and then prevent cardiovascular 
disease[13].  
The comprehensive collection of these metabolites within cells, biofluids, tissues, 
or organisms is known as metabolomics. Metabolite profiling can provide an 
instant snapshot of the physiology of the cell. Therefore, metabolomics can 




Liquid chromatography with tandem mass spectrometry (LC-MS/MS) is one of 
the most powerful commercial analytical techniques. Liquid chromatography 
provides separating power, and mass analysis is finished with high sensitivity and 
selectivity of detection using a mass spectrometer. An LC-MS/MS's general 
composition includes a sample injection unit, an ionization interface, a mass 
analyzer, an ion detector, and a data analysis module for output. According to 
different polarities, analytes are separated in liquid chromatography, causing 
different interaction times with the stationary phase and the mobile phase. 
Analytes are ionized at the interface between LC and MS systems, electrospray 
ionization (ESI) in this experiment[16]. Under high voltage, the mobile phase is 
transferred into an aerosol. The same charge on the liquid droplets expels each 
other. The solvent is evaporated in this process, and charged analytes are left and 
transmitted into the mass analyzer for subsequent analysis[16].  
 
The orbitrap combines the functions of analyzer and detector. With two outer 
electrodes and a central electrode, analyte ions are first trapped and then do a 
waving movement along the central electrode's axis. Ions move forward and 
backward following angular frequency, which has the following relation to their 
mass-to-charge ratios m/z and ω = √k/(m/z). A field inside the electrode reduction 
will cause ions ejection [17].   
 
The best conditions for mass spectrometry acquisition depend on the device, 
including ion source and analyzer parameters, in addition to all the techniques 
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discussed earlier. The data is usually collected in full scan mode for an untargeted 
test, in which the instrument is set to scan the full mass spectrum from 50 to 1200 
m/z. 
 
Data pre-processing was finished on software MZmine2 version 2.40.1[18]. It has 
the feature of the ability to handle large file sizes of raw data. Standard processing 
procedures include the following steps: (1) peak detection for noise removal 
according to noise ratio (S/N), (2) chromatography builder and deconvolution for 
peak extraction, in which specific algorithms are selected under different 
circumstances, (3) isotope grouping for merging peaks with 1 m/z difference, (4) 
feature alignment to focus on the valid molecule peaks with m/z and retention 
time parameters. All pre-processing data procedures are aiming for convincing 
mass spectrometry analysis results for metabolites annotation[19]. 
 
Our project's most crucial dereplication method is molecular networking based on 
Global Natural Products Social Molecular Networking (GNPS)[20]. It contributes 
to annotate known metabolite results from complex biological extract analytes 
rapidly. The chemical similarity of MS/MS data is the main focus of helping 
organize molecular networking. The MS / MS spectra of mixtures of natural 
products and known standards, synthetic compounds, or organisms with good 
characteristics can be successfully reproduced using molecular networks, which 
should be organized into reliable databases. This method can be adapted to 
different ionization platforms and correlate MS / MS data from environmental 
6 
 
ionization, direct injection, and LC-based methods. Molecular networks can 
annotate known molecules from complex mixtures and capture related analogs, 
which is a challenge for many other annotation strategies[21].  
 
We apply liquid chromatography-mass spectrometry-based molecular networking 
to germ-free and conventional mice's hearts section samples to illustrate 
significant profiling differences. Four metabolites, glutamine, ergothioneine, and 
neighborhood molecules of dodecanoic acid and adenosine 5’ diphosphoribose, 
showed statistically significant difference by Random Forest analysis and PRM 
quantification validation. These molecules followed our hypothesis that 
metabolites would reduce cardiovascular disease risk, but this needs further 
validation.  
 
2. Results  
The principal coordinate analysis was applied to provide a snapshot for overall 
molecular diversity mapping across mice heart sections and conditions. Moreover, 
a machine learning method, the random forest, was used to pick up metabolic 
features from global natural product social (GNPS) molecular networking 
platform annotated results. 
2.1. Overall metabolite profiling between heart sections of CONV-R and germ-free 
mice 
Metabolites from six heart sections from 8 GF and 5 conventional 6mice were 
processed with aqueous and organic extraction and analyzed by LC-MS/MS. To 
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compare the overall metabolites profile between different heart sections and 
conditions, PCoA (principal coordinate analysis) was performed on MZmine2-
processed LC-MS/MS results. Relative higher differences were shown between 
heart sections (Figure 1a, PERMANOVA p=0.001 R2=48.89%), driven by the 
difference between the atrium and the other sections. No overall impact of germ-
free vs. colonized condition was observed (Figure 1b. PERMANOVA p=0.786 
R2=5.152%). The limitation of PCoA is that an obvious mapping distinction 
appears only when there are large differences, without determining the specific 





Figure 1. Principal coordinate analysis (PCoA) of comprehensive mapping to show 
differences between sections and conditions. 
2.2. Impact of colonization status on short-, mid-, and long-chain acylcarnitines  
Acylcarnitines, which are converted from carnitine by enzymes, play an 
important role as substrates in fat catabolism[22]. We studied acylcarnitines 
between CONV-R and germ-free conditions because of their role in fat 
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metabolism and other energy metabolism. Acylcarnitines with spectral 
annotation in GNPS (Global Natural Product Social Networking platform) 
were selected. The MS/MS spectra of all selected ones' neighboring 
molecules in molecular networking were visually examined to confirm the 
presence of a diagnostic peak at m/z=85.0288 with matching in MS/MS 
spectral fragment pattern. Different carbon chain lengths divided 
acylcarnitines into three groups: short-chain, medium length chain, and 
long-chain acylcarnitines. The normalized peak intensity of three 
acylcarnitines groups was summed up and analyzed by boxplot (Figure 2a-
d.). As shown in figures, the left ventricle free wall had an apparent higher 
medium length acylcarnitines in CONV-R than germ-free mice. However, 
this was driven by an outlier in the CONV-R group. Acylcarnitines did not 





Figure 2. boxplots of acylcarnitine relative peak intensity between different sections and 
conditions. 
2.3. Impact of colonization status on the ratio of oxidized to reduced glutathione  
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Glutathione has an ability on antioxidation, which can protect cells from 
being damaged by reactive oxygen species[23]. The glutathione groups 
were found to follow the same processing as described above for 
acylcarnitine. P values were applied to statistically analyze the existence 
of significant differences between different regional sections and 
conditions. However, there was no statistically significant difference 
shown in data.  
 
Figure 3. Boxplot of glutathione relative peak intensity between different sections and 




2.4. Random Forest analysis 
Based on the limitation of PCoA, a machine learning approach called 
Random Forest (RF) was performed to identify specific metabolite 
molecules that differ between CONV-R and germ-free mice hearts. The 
top 20 molecular features in 6 different sections were listed according to 
MeanDecreaseAccuracy values. We also manually made boxplots (Figure 
S1.) for these molecules to exclude ones with outliers.  
2.5. Parallel Reaction Monitoring (PRM) 
The results from the untargeted LC-MS experiment had a limited precision 
for quantification. Furthermore, the Random Forest result also needed a 
more convincing validation. The Parallel Reaction Monitoring (PRM) 
experiment was designed to make up for the limitations. The following 
boxplots (Figure 4-7.) were generated from PRM results and normalized 
by the internal standard sulfadimethoxine added to PRM run with the 
same amount in LC-MS experiment[24]. 
2.6. Glutamine 
L-glutamine is the human body’s most concentrated amino acid. In 
different applications, it is used in human body as protein's biosynthesis 
and substance transportation in blood and defense against viruses and 
bacteria[25]. In random forest results, it showed differences in several 
sections between CONV-R and germ-free conditions. Its abundance was 
higher in CONV-R mice right ventricle free wall and lowered in the left 
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ventricle free wall bottom. Glutamine can drive the essential processes of 
vascular cells, including proliferation, replication, apoptosis, ageing, and 
extracellular matrix deposition, as a substrate for the synthesis of DNA, 
ATP, proteins and lipids. In addition, through stimulating the expression 
of heme oxygenase-1, heat shock protein and glutathione, glutamine plays 
a potent anti-inflammatory and anti-inflammatory function in circulation. 
Significantly, the risk factors for certain cardiovascular diseases, such as 
hypertension, hyperlipidemia, glucose intolerance, obesity and diabetes, 
may be minimized by glutamine[26]. 
 
Figure 4. L-glutamine (m/z = 130.05) boxplot. 
2.7. m/z = 177.13, neighbor molecule of dodecanoic acid 
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This molecule is a neighborhood of dodecanoic acid in molecular 
networking, which means a similar structure and main function groups. 
Dodecanoic acid, also known as lauric acid, is a saturated fatty acid 
usually delivered to the liver and transformed into energy instead of fat. 
That is because lauric acid is a medium-chain fatty acid covering C6-C12, 
different from long-chain fatty acids covering C14 and longer. In terms of 
lipoprotein metabolism, lauric acid higher concentration tends to increase 
low-density lipoprotein (LDL) levels. However, they have a more 
significant proportion of high-density lipoprotein (HDL) levels, resulting 
in decreased total cholesterol/HDL cholesterol levels. Lauric acid 
increases the ratio of total to HDL cholesterol, which may reduce 




Figure 5. neighbor molecule of dodecanoic acid (m/z = 177.13) boxplot of peak 
abundances from PRM results between different conditions and heart sections. 
2.8. m/z = 230.1. ergothioneine 
Ergothioneine is an amino acid present mainly in mushrooms, and there is 
no way to synthesize it in the human body; it can also be found in oat 
bran. Ergothioneine accumulates to nanomoles in human and animal 
tissues through its high-affinity transporters. The daily diet is the primary 
source to accumulate it by a human. The chemical redox reaction of 
ergothioneine and alkylthiols, such as cysteine and glutathione, provides a 
new perspective for ergothioneine's role in oxidative damage. 
Furthermore, it has just proved in recent work that higher ergothioneine 
could be a biomarker at a lower risk of cardiovascular disease[29,30]. In this 
last project, ergothioneine was statistically proved to indicate a significant 
association with a reduced risk of cardiovascular and CAD mortality. 
Multivariable Cox regression analyses were applied to verify the relation. 
Moreover, the previous research found that ergothioneine could be 
suggested to be a more controlled antioxidant because of its specific 




Figure 6. ergothioneine boxplot of peak abundance results from PRM quantification 










2.9. m/z = 588.11, neighbor molecule of adenosine 5’ diphosphoribose 
Figure 7a. ADP-ribose neighbor molecule PRM results in normalized boxplot between 
different conditions and sections. 7b. red circle labeled molecule (m/z = 588.11) and the 
green circle labeled annotated adenosine 5’-diphosphoribose in molecular networking. 
Each node on molecular networking represents one molecule. Edge between nodes 
represents similarity of the MS2 fragment patterns. 
The m/z = 588.11 molecule has an annotated neighborhood, which is 
Adenosine 5’-diphosphoribose, also known as ADP-ribose. The short edge 
between them means they have a similar molecule structure and function 
groups. The most abundant isoform in the PARP molecule family is the 
polymerase 1 of ADP-ribose (PARP-1). PARP-1 was shown to 
accumulate evidence that certain reactive oxygen and nitrogen species that 
are formed in endothelial and cardiomyocyte cells during heart failure, 
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cardiovascular ageing, and cardiomyopathy may be activated. Recently, 
PARP was developed to be inhibitors and applied in clinical usage for 
various cardiovascular indications. It has proved to have a significant 
advantage in animal models of cardiovascular disorders[32]. In our project, 
the neighborhood molecule of ADP-ribose showed relatively higher 
abundance in the right ventricle free wall and left atrium sections in germ-
free condition than the CONV-R condition. 
 
3. Discussion 
In this project, we analyzed metabolites in germ-free and CONV-R mice 
hearts regionally. Because there are some specific kinds of metabolites 
interested in researchers, we also made boxplots and statistical analysis on 
acylcarnitine with different chain lengths and glutathione with the 
oxidized glutathione[33,34]. Nevertheless, the two kinds of metabolites did 
not show a statistically significant difference in mice heart samples.   
With Random Forest analysis, we found 26 metabolite molecules with 
different amounts between germ-free and CONV-R mice hearts. We did 
PRM test and found the following results. Four molecules included L-
glutamine, ergothioneine, and neighbor molecules of dodecanoic acid and 
ADP-ribose in molecular networking. These four metabolites all showed a 
statistically significant difference in the right ventricle free wall, left 
atrium, or two sections. Ergothioneine had a statistical difference in the 
left ventricle free wall top section. All four metabolites had a relationship 
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with a low risk of cardiovascular disease. L-glutamine can reduce the risk 
factors directly with the anti-inflammatory function. Lauric acid could 
increase the ratio of total cholesterol to HDL to affect the risk of CVD. 
The ergothioneine was also a biomarker that represents a lower risk of 
CVD[26]. 
Our major strength was the mice model design and metabolomic study 
combined with regional analysis. Other studies have performed mapping 
of metabolites. For example, for metabolite mapping analysis of brain, 
interleaved water reference was applied to combined with a volumetric 
MR spectroscopic imaging (MRSI) acquisition[35]. In contrast, our project 
specifically focused on the heart. Compared with other similar works 
before, our project combined the 3D structure of mice hearts to analyze 
the metabolite difference. 
The main limitation is the sample amount. Some of the heart sections were 
too-small sample to reduce the sample loss in the preparation step. 
Furthermore, that is why we ran PRM to decrease the adverse effects. The 
results turned out to be optimized to a convincing quantification now.  
4. Conclusion 
We controlled the microbiome by utilizing of germ-free mice model and 
re-colonized them to generate our CONV-R mice as a comparison. 
Twenty-six metabolites were picked up and related to microbiome 
presence. The microbiome correlated with metabolite changes in different 
sections of mice's hearts. Parallel reaction monitoring (PRM) was a critical 
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quantification step to assess our relative peak abundance differences 
between conditions and heart sections. Four metabolites selected from 
PRM results interested us because they or their neighbors are known as 
molecules that could prevent cardiovascular disease. 
Moreover, we could also learn the germ-free mice model's limitation 
because the lack of microbiome might induce an increased risk of certain 
diseases. To dig deeper based on our current research, microbiomes will 
be the primary study direction because the mechanism to generate our 
interesting metabolites is essential to learn. However, the project 
represents a step forward to more understanding the microbiome. 
 
5. Materials and Methods 
5.1. In vivo experiment 
Half of 12-week-old GF C57/BL6 mice were colonized with microbiota 
from conventionally raised (CONV-R) mice, and the other half of mice 
were kept GF. 8 GF and 5 CONV-R mice were alive until 14 weeks. All 
animals were fed a chow diet and were echoed at 14 weeks of age to 
assess structural and functional differences. Mice were euthanized by CO2 
asphyxiation at 14 weeks. Hearts were cut into six sections: left atrium 
(LA), right atrium (RA), right ventricle free wall (RVFW), septum, left 
ventricle free wall top (LVFWT) and left ventricle free wall bottom 
(LVFWB). Heart samples were transported to McCall lab at the University 
of Oklahoma and stored at -80℃.  
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5.2. Sample preparation for LC-MS/MS 
All solutions in this section were LC-MS grade. Heart samples were 
weighed and mixed with water with volume normalization by 50mg 
sample to 250 μL 50% methanol. For some specific samples with limited 
weights, 50% of methanol volumes were adjusted to normalize within 10 
μL error. Samples were then homogenized in a TissueLyzer II (Qiagen) 
with a 5 mm stainless steel bead (Qiagen) at 25Hz for 5 min. Aqueous 
fractions were extracted from supernatants after centrifugation (14,800 
rpm, 10min) at 4℃ and plated out up to 160-180 μL (according to 
different sample amounts) 96 well plates. The plate was then dried in a 
vacuum concentrator (SpeedVac, Savant SPD 111V, ThermoFisher 
Scientific). Pellets were resuspended with 3:1 dichloromethane: methanol 
(spiked with 0.5 μg/mL sulfachloropyridazine) and homogenized at 25 Hz 
5 min, followed with centrifugation at 14800 rpm for 10 min for organic 
extraction. The supernatants were dried into and stored at -80℃ for later 
LC-MS/MS analysis. 
 
5.3. Liquid chromatography-tandem mass spectrometry 
The pellets were resuspended to 150 μL with 1:1 methanol: water, spiked 
with 0.5 μg/mL sulfadimethoxine (internal control). Liquid 
chromatography was performed on a ThermoScientific Vanquish UHPLC 
system equipped with 1.7 μm 100 Å Kintex C8 column (50 X 2.1 mm) 
(Phenomenex). The column effluent was analyzed using a Q Exactive Plus 
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(ThermoScientific) high-resolution mass spectrometer fitted with heated 
electrospray ionization (HESI) interface in positive ion mode. Calibration 
was done with commercial Calmix standard (ThermoFisher) consisting of 
MRFA, caffeine, Ultramark 1621, and n-butylamine in 
acetonitrile/MeOH/acetic acid solution. 
Table 1. Instrument Parameters for Full MS/dd-MS2 
Properties of Full MS/dd-MS2 
General 
Runtime 0 to 7.5 min 
Polarity Positive 




AGC target 1e6 
Scan Range 70 to 1050 m/z 
Maximum IT 246 ms 
dd-MS2 
Resolution 17,500 
AGC target 2e5 
Maximum IT 54 ms 
Loop count 5 
TopN 5 
Isolation window 1.0 m/z 
Fixed mass - 
(N)CE/stepped NCE: 20, 40, 60 
dd Settings 
Minimum AGC 8.00e3 
Peptide Match Preferred 
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Exclude isotopes on 
Dynamic exclusion 10.0 s 
 
Table 2. Instrument Parameters for HESI source 
Properties of HESI source 
General 
Sheath gas flow rate 35 
Aux gas flow rate 10 
Sweep gas flow rate 0 
Spray voltage (|kV|) 3.80 
Spray current (µA)  
Capillary temp. (℃) 320 
S-lens RF level 50.0 
Aux gas heater temp (℃) 350 
 
 
5.4. Data analysis 
Raw MS data were converted to mzXML format using MSconvert 
software[36,37]. The output mzXML files were processed in MZmine 
version 2.40.1[18] (see Table 3 for parameters). Principal coordinate 
analysis (PCoA, bray-curtis-faith distance metric) and Random Forest 
were performed in Jupyter notebook with R (http://jupyter.org). 
Metabolites feature annotation was finished on the Global Natural 
Products Social Networking (GNPS) platform[20] and visualized as 
molecular networking in Cytoscape[38,39].  
Table 3. MZmine processing parameters. 
Procedure  Parameter 
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Mass Peak Detection MS level 1: Noise level 2.0E5 
 MS level 2: Noise level 1.0E3 
 Mass detector Centroid 
Chromatogram Builder Scans MS1 
 Mass list Masses 
 Min time span (min) 0.1 
 Min height 5.0E5 
 m/z tolerance 1.0E-6 m/z (or 10 ppm) 
Chromatogram Deconvolution Algorithm Local minimum search 
 Chromatographic threshold 20% 
 Search minimum in RT range (min) 0.20 
 Minimum relative height 30.0% 
 Minimum absolute height 5.0E5 
 Min ratio of peak top/edge 1.19 
 Peak duration range (min) 0.01-2.40 
 m/z center calculation Median 
 m/z range (Da) 0.01 
 RT range (min) 0.2 
Isotopic Grouping m/z tolerance 1.0E-6 m/z (or 10 ppm) 
 Absolute RT tolerance (min) 0.05 
 Monotonic shape Yes 
 Maximum charge 3 
Feature Alignment m/z tolerance 1.0E-6 m/z (or 10 ppm) 
 Weight for m/z 10 
 Absolute RT tolerance 0.5 
 Weight for RT 1 
Peak List Row Filter Minimum peaks in a row 3 
 RT (min) 0.20-7.51 
 Keep only peaks with MS2 scan (GNPS) Yes 
 Reset the peak number ID Yes 
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Gap filling m/z tolerance 0.001m/z (or 5 ppm) 
 Intensity tolerance 25% 
 Absolute RT tolerance (min) 0.1 
 RT correction Yes 
   
 
5.5. Amino acids standards MS data collection 
Ten amino acid standards (Sigma-Aldrich) were selected, consisting of 
arginine, methionine, tryptophan, histidine, lysine, threonine, valine, 
isoleucine, leucine, and phenylalanine. 100 mM solution was prepared 
with 3:1 dichloromethane: methanol (spiked with 0.5 μg/mL 
sulfadimethoxine) for each standard. Serial dilutions were performed to 
make lower concentration solutions as 1 μM and 10 mM. Diluted solutions 
were plate out 150 μL in 96 well plates and analyzed with untargeted LC-
MS/MS. 
5.6. Parallel monitoring reaction 
Top 37 metabolites were selected from boxplots combined with Random 
Forest[40] results, classifying based on the germ-free and conventionally-
raised status between different heart sections. The transition list was 
generated to include m/z and RT of the 25 metabolites and 2 internal 
standards. The parallel monitoring reaction was applied as an LC-MS/MS 
run under the same method with the transition list uploaded for targeting. 
The output PRM raw dataset was imported into Skyline (SL) software for 
quantification results processing (see Table 4 for parameters).  
Table 4. Instrumental parameters for PRM 
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Properties of PRM 
General 
Runtime 0 to 7.5 min 
Polarity Positive 




AGC target 2e5 
Maximum IT 54 ms 
Isolation window 1.0 m/z 
Fixed first mass - 
(N)CE / stepped nce 20, 40, 60 
 
Table 5. PRM Skyline processing parameters. 
Procedure  Parameter 
Prediction Precursor mass Monoisotopic 
 Product ion mass Monoisotopic 
 Collision energy None 
 Declustering potential None 
 Optimization library None 
 Compensation voltage None 
Filter Precursor adducts [M+H] 
 Fragment adducts [M+] 
 Ion types f, p 
Library Ion match tolerance 0.5 m/z 
 If a library spectrum is available, pick its most intense ions. Yes 
 Pick 3 product ions 
 From filtered ion adducts and types Yes 
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Instrument Min m/z 50 
 Max m/z 1500 
 Method match tolerance m/z 0.055 
Full-scan Isotope peaks included Count 
 Precursor mass analyzer Orbitrap 
 Peaks 3 
 Resolving power 70 At: 200 m/z 
 Isotope labeling enrichment Default 
 Acquisition method Targeted 
 Product mass analyzer Orbitrap 
 Resolving power 17,500 At: 200 m/z 
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Table S1. 25 metabolite molecules selected from Random Forest results.  
m/z Retention time Library hit (neighbor annotation) 
106.05 0.28 Serine 
130.05 0.27 L-glutamine 
134.04 1.73 Aspartic acid 
135.08 2.27 Azelaic acid 
136.05 0.26 Adenosine monophosphate 
137.1 2.41 (2-tert-Butryl-p-quinone) 
146.12 0.26 (Spermidine|N-(3-aminopropyl)butane-1,4-diamine) 
147.08 0.27 Glutamine|2,5-diamino-5-oxopentanoic acid 
148.06 0.27 alpha.-Guanidinoglutaric acid 
150.06 0.27 Methionine 
156.08 0.26 Histidine 
175.12 0.25 Arginine 
177.13 2.63 (Dodecanedioic acid) 
182.08 0.29 Tyrosine 
189.16 0.27 NEPSILON,NEPSILON,NEPSILON-TRIMETHYLLYSINE 
205.1 0.7 L-tryptophan 
230.1 2.17 Ergothioneine 
251.04 0.53 (Guanidinoethyl sulfonate) 
280.26 2.99 (13-Docosenamide, (Z)-) 
482.42 3.03 (Linoleoyl carnitine) 















phosphocholine from NIST14 
886.54 3.53 (1-Docosahexaenoyl-2-stearoyl-sn-glycero-3-phosphocholine) 
 
Figure S1. Untargeted LCMS results boxplots of 25 molecules selected from Random Forest results. 
 
 
 
 
